Plato

Plato is a biotechnology company developing a high-throughput proteomics platform designed to map the interactions between small molecules and the human proteome at an unprecedented scale. By integrating advanced mass spectrometry with machine learning, the company aims to identify novel therapeutic targets and optimize drug candidates with high resolution and speed. Plato's technology enables the systematic discovery of drug-protein interactions, facilitating the development of treatments for previously undruggable conditions. The company is focused on uncovering new biology to address complex diseases across various therapeutic areas, including oncology and immunology.